● Important Update

Charles River Laboratories Has Completed the Sale of Its CDMO & Cell Supply Business

These operations are now part of Rose BioSolutions, a newly formed company backed by GI Partners. Here's what that means for current and future colleagues.

Effective Q2 2026

A Message to Our Candidates & Colleagues

At Rose BioSolutions, we believe transparency and trust are foundational to every relationship we build. Our commitment to candidates and colleagues remains unwavering as we continue to grow and evolve.

We work closely with our partners across the life sciences industry to ensure alignment, clarity, and respect throughout the hiring and collaboration process. Every interaction reflects our values and expectations.

Thank you for placing your trust in Rose BioSolutions. We appreciate the opportunity to support your journey and look forward to building meaningful partnerships together.

Transaction at a Glance

Key Details

🏢
Acquiring Company
Rose BioSolutions
Parent organization completing the transaction
🔬
Businesses Divested
CDMO & Cell Supply
Core operating units included in the divestiture
📍
Sites Involved
4 Locations
Facilities and operational hubs affected
📅
Transaction Close
Q2 2026
Expected completion timeframe

What This Means for You

If You Applied for a Role at a CDMO or Cell Supply Site Active Candidates

Applications submitted for CDMO and Cell Supply roles are still under review. Recruitment teams will communicate next steps as timelines align with the Q2 2026 transaction close.

If You Are Exploring Career Opportunities Prospective Candidates

New opportunities will continue to be posted as integration planning evolves. We encourage prospective candidates to follow Rose BioSolutions for future openings and role announcements.

Questions & Answers

Frequently Asked Questions

Does this divestiture affect all Charles River sites?
No. Only specific CDMO and Cell Supply sites are included in this transaction. Other Charles River Laboratories locations and business units remain unchanged.
Who is Rose BioSolutions?
Rose BioSolutions is a newly formed company backed by GI Partners, created to operate the acquired CDMO and Cell Supply businesses following the transaction.
Will open roles at the divested sites still be posted on jobs.criver.com?
During the transition period, some roles may still appear on jobs.criver.com, but hiring responsibility will gradually move to Rose BioSolutions.
I previously submitted my resume to a CRL CDMO role. What happens to my application?
Applications already submitted will remain under consideration. Candidates will be contacted directly if next steps or transitions apply.
What kinds of roles is Charles River currently hiring for?
Charles River continues to hire across research models, discovery, safety assessment, and other core service areas unrelated to the divested businesses.